Filing Details
- Accession Number:
- 0001104659-11-053334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-26 20:45:13
- Reporting Period:
- 2011-09-23
- Filing Date:
- 2011-09-26
- Accepted Time:
- 2011-09-26 20:45:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1130166 | Cyclacel Pharmaceuticals Inc. | CYCC | Pharmaceutical Preparations (2834) | 911766850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1357397 | Paul Mcbarron | 200 Connell Drive, Suite 1500 Berkeley Heights NJ 07922 | Evp, Finance, Cfo, Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Acquisiton | 2011-09-23 | 12,000 | $0.50 | 188,054 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 14,576 shares of restricted stock subject to forfeiture until vested.
Billionaire Hedge Funds
